XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung and heart therapies on one single platform.
- the unique platform for three applications combining ICU (novalung: iLA activve system platform), cath lab (i-cor: i-cor system) and OR (medos: deltastream system)
- adapt the system to your needs
- increased safety through integrated emergency functions